The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects. (Q54515616)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects. |
scientific article |
Statements
The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects. (English)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Monica Tortoreto
1 reference
Daniela Passeri
1 reference
Angela Maria Di Francesco
1 reference
Federica Bucci
1 reference
Claudio Pisano
1 reference
Franco Zunino
1 reference
13 April 2012
1 reference
84
1 reference
163-171
1 reference
2
1 reference
Identifiers
1 reference